## LITE: Lumentum Holdings Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.97 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: declining volume (52% of avg), momentum weakening (-8.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($325.96)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Three Seasons Wealth LLC Takes $720,000 Position in Lumentum Holdings Inc. $LITE**
- Source: MarketBeat | 20251229T120947 | Bullish | Relevance: 100%
- Three Seasons Wealth LLC has acquired a new position in Lumentum Holdings Inc. (NASDAQ:LITE), purchasing 4,425 shares valued at approximately $720,000 during the third quarter. Lumentum reported strong earnings, beating EPS estimates and showing significant year-over-year revenue growth. Despite high institutional ownership, insiders have recently sold a notable amount of shares.

**2. Lumentum Stock Surges Following Strategic Moves and Market Optimism**
- Source: StocksToTrade | 20251229T220947 | Somewhat-Bullish | Relevance: 100%
- Lumentum Holdings Inc.'s stock (NASDAQ: LITE) has been trending down by 4.21% despite strategic moves like acquisitions and investments in emerging optical and photonic technologies. Investors are showing increased confidence due to these strategic shifts and the anticipated demand for optical devices in communication networks. The company's financial overview shows steady revenue growth, robust gross margin, and impressive return on equity, though concerns exist regarding its debt-to-equity ratio.

**3. Lumentum (NASDAQ:LITE) Stock Price Down 6.5% - Here's Why**
- Source: MarketBeat | 20251229T180947 | Somewhat-Bearish | Relevance: 100%
- Lumentum (NASDAQ:LITE) stock fell 6.5% on Monday despite reporting a strong quarter with $1.10 EPS against an expected $1.03 and revenue up 58.4% year-over-year. The company also provided Q2 2026 guidance for EPS between $1.30 and $1.50. Despite a "Moderate Buy" consensus from analysts, the average price target of $222.13 is significantly below the current trading price, and recent insider selling along with high institutional ownership present mixed signals for investors.

**4. Lumentum Holdings Inc. $LITE Shares Sold by Thompson Investment Management Inc.**
- Source: MarketBeat | 20251228T120930 | Neutral | Relevance: 100%
- Thompson Investment Management Inc. reduced its stake in Lumentum Holdings Inc. by 20.5% in the third quarter of 2025, selling 15,861 shares. Corporate insiders, including SVP Jae Kim and Director Isaac Hosojiro Harris, also sold a significant number of shares, totaling $7.32 million in the last quarter. Despite these insider sales, Lumentum beat quarterly earnings estimates and provided strong Q2 FY2026 guidance, though its stock trades at a high P/E ratio.

**5. Swedbank AB Makes New $9.70 Million Investment in Lumentum Holdings Inc. $LITE**
- Source: MarketBeat | 20251228T100931 | Bullish | Relevance: 100%
- Swedbank AB has made a new investment of $9.70 million in Lumentum Holdings Inc., acquiring 59,600 shares and now owning 0.08% of the company. Lumentum recently exceeded quarterly earnings estimates and provided strong Q2 2026 guidance. While the stock has a "Moderate Buy" consensus and high institutional ownership, insiders have recently sold shares.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $304 | $190 | +60% |
| 2025-12-04 | Rosenblatt | $380 | $280 | +36% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-04 | Rosenblatt | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 14 ($9.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Blackrock Inc.: 11.2% (+7.6%)
- Vanguard Group Inc: 10.6% (+0.6%)
- FMR, LLC: 8.4% (-10.6%)
- Capital World Invest: 5.7% (-29.3%)
- Invesco Ltd.: 3.2% (-41.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-8.3% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $9.5M in recent transactions.
3. High short interest (19.8%, 2.5 days to cover): squeeze risk or crowded bearish bet.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.97 indicates undervaluation relative to growth. Revenue growth strong at 31% YoY. Analyst sentiment positive (2 raises, avg +48%). Insider selling cluster ($9.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.3B |
| Beta | 1.53 |
| 52W Range | $45.65 - $401.60 |
| Short Interest | 19.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.97 |
| Forward P/E | 45.4 |
| Current P/E | 65.3 |
| YoY Growth | 43.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 14.0% to 5.7% (-8.3% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 97th percentile. MRS_5 (-2.8%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.8% shows strong absolute momentum above own 20MA. Outperforming sector by 5.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-1.20), momentum weakening. Volume at 52% of 20MA suggests lack of conviction. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.68% (CS: 97) | Strong |
| RSI_14 | 60.8 | Neutral |
| MACD Histogram | -1.20 | Bearish |
| vs SMA20 | 1.058x | Above |
| vs SMA50 | 1.328x | Above |
| vs SMA200 | 2.544x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $371.18
- **Stop Loss:** $325.96 (12.2% risk)
- **Target:** $461.62 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $8,908.32
- **Portfolio %:** 8.91%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-05 (Est: $1.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.03 | $1.10 | +7.0% |
| 2025Q2 | $0.81 | $0.88 | +8.9% |
| 2025Q1 | $0.50 | $0.57 | +13.7% |
| 2024Q4 | $0.36 | $0.42 | +17.0% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*